4/A
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-004233
Chief Executive Officer sold 50,000 shares at $36.80 ($1,840,000)
- Chief Executive Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2023-02-02 | Option exercise | +50,000 | $0.15 | $7,500 | 530,905 | D |
| Violin Jonathan Chief Executive Officer | 2023-02-02 | Sale | −50,000 | $36.80 | $1,840,000 | 480,905 | D |
| Derivatives | |||||||
| Violin Jonathan Chief Executive Officer | 2023-02-02 | Option exercise · Stock Option (Right to Buy) | −50,000 | 239,205 | D | ||
| Open-market sales · 50,000 sh · avg $36.80 · $1,840,000 | |||||||
Loading xslF345X03/doc4a.xml…